MacroGenics Issuance Of Capital Stock from 2010 to 2024

MGNX Stock  USD 4.83  0.36  8.05%   
MacroGenics Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 585.2 K in 2024. During the period from 2010 to 2024, MacroGenics Issuance Of Capital Stock regression line of annual values had r-squared of  0.26 and arithmetic mean of  89,236,547. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
616 K
Current Value
585.2 K
Quarterly Volatility
48.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of MacroGenics over the last few years. It is MacroGenics' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

MacroGenics Issuance Of Capital Stock Regression Statistics

Arithmetic Mean89,236,547
Geometric Mean40,394,188
Coefficient Of Variation54.84
Mean Deviation35,389,792
Median103,259,000
Standard Deviation48,940,257
Sample Variance2395.1T
Range169.9M
R-Value(0.51)
Mean Square Error1915.3T
R-Squared0.26
Significance0.05
Slope(5,552,934)
Total Sum of Squares33532.1T

MacroGenics Issuance Of Capital Stock History

2024585.2 K
2023616 K
20221.1 M
2021117.8 M
2020170.5 M
2019118.7 M

About MacroGenics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MacroGenics income statement, its balance sheet, and the statement of cash flows. MacroGenics investors use historical funamental indicators, such as MacroGenics's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Although MacroGenics investors may use each financial statement separately, they are all related. The changes in MacroGenics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MacroGenics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MacroGenics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock616 K585.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.